These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 9581329

  • 1. New and emerging drug treatments for hypertension.
    Krum H, Pellizzer AM.
    Aust Fam Physician; 1998 Apr; 27(4):235-7, 240-2. PubMed ID: 9581329
    [Abstract] [Full Text] [Related]

  • 2. [Rational hypertension treatment].
    Canova CR.
    Schweiz Med Wochenschr; 1996 Aug 17; 126(33):1394-9. PubMed ID: 8830397
    [Abstract] [Full Text] [Related]

  • 3. Long-term safety of antihypertensive therapy.
    Grossman E, Messerli FH.
    Prog Cardiovasc Dis; 2006 Aug 17; 49(1):16-25. PubMed ID: 16867847
    [Abstract] [Full Text] [Related]

  • 4. [Are the newer antihypertensive agents better and more effective than diuretics?].
    Landmark K.
    Tidsskr Nor Laegeforen; 2001 Feb 28; 121(6):701-5. PubMed ID: 11293353
    [Abstract] [Full Text] [Related]

  • 5. [Hypertension 2007-2008].
    Chatzikyrkou C, Menne J, Haller H.
    Med Klin (Munich); 2009 Aug 28; 104(8):614-21. PubMed ID: 19701732
    [Abstract] [Full Text] [Related]

  • 6. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr 28; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T, Linjer E, Hedner T, Lanke J, De Faire U, Wester PO, Dahlöf B, Scherstén B.
    Blood Press; 2004 Apr 28; 13(3):137-41. PubMed ID: 15223721
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Pharmacological hypertension therapy].
    Pedersen OL, Christensen KL, Bang LE, Ibsen H, Schultz-Larsen P.
    Ugeskr Laeger; 2009 Jun 08; 171(24):2022-5. PubMed ID: 19523367
    [Abstract] [Full Text] [Related]

  • 10. [Hypertension therapies compared. Are the new nevertheless better than the old?].
    MMW Fortschr Med; 2005 Mar 24; 147(12):6, 8. PubMed ID: 15832780
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Angiotensin II antagonists in the treatment of hypertension-effective and efficient?
    Müller-Nordhorn J, Willich SN.
    Herz; 2003 Dec 24; 28(8):733-7. PubMed ID: 14689108
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Selecting antihypertensive medication in patients with essential hypertension in Malaysia.
    Ong HT, Rozina G.
    Med J Malaysia; 2009 Mar 24; 64(1):3-11. PubMed ID: 19852313
    [No Abstract] [Full Text] [Related]

  • 17. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C, Croce G, Desideri G.
    Adv Ther; 2008 Apr 24; 25(4):300-20. PubMed ID: 18449492
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.